Moreover, subjects with the CC or CT MTHFR genotype had the highest risk of stroke and the greatest benefit of folic acid supplementation while those with the TT genotype required a higher dosage of folic acid to reach sufficient levels [80]. Here, MTHFR is linked to stroke disorder.